Literature DB >> 25670500

AbDesign: An algorithm for combinatorial backbone design guided by natural conformations and sequences.

Gideon D Lapidoth1, Dror Baran1, Gabriele M Pszolla1, Christoffer Norn1, Assaf Alon1, Michael D Tyka2, Sarel J Fleishman1.   

Abstract

Computational design of protein function has made substantial progress, generating new enzymes, binders, inhibitors, and nanomaterials not previously seen in nature. However, the ability to design new protein backbones for function--essential to exert control over all polypeptide degrees of freedom--remains a critical challenge. Most previous attempts to design new backbones computed the mainchain from scratch. Here, instead, we describe a combinatorial backbone and sequence optimization algorithm called AbDesign, which leverages the large number of sequences and experimentally determined molecular structures of antibodies to construct new antibody models, dock them against target surfaces and optimize their sequence and backbone conformation for high stability and binding affinity. We used the algorithm to produce antibody designs that target the same molecular surfaces as nine natural, high-affinity antibodies; in five cases interface sequence identity is above 30%, and in four of those the backbone conformation at the core of the antibody binding surface is within 1 Å root-mean square deviation from the natural antibodies. Designs recapitulate polar interaction networks observed in natural complexes, and amino acid sidechain rigidity at the designed binding surface, which is likely important for affinity and specificity, is high compared to previous design studies. In designed anti-lysozyme antibodies, complementarity-determining regions (CDRs) at the periphery of the interface, such as L1 and H2, show greater backbone conformation diversity than the CDRs at the core of the interface, and increase the binding surface area compared to the natural antibody, potentially enhancing affinity and specificity.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  CDRs; Rosetta; V(D)J recombination; canonical conformations; computational protein design; conformation-sequence optimization; fuzzy-logic design; modular segments

Mesh:

Substances:

Year:  2015        PMID: 25670500      PMCID: PMC4881815          DOI: 10.1002/prot.24779

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  111 in total

1.  H3-rules: identification of CDR-H3 structures in antibodies.

Authors:  H Shirai; A Kidera; H Nakamura
Journal:  FEBS Lett       Date:  1999-07-16       Impact factor: 4.124

2.  Maturation of an antibody response is governed by modulations in flexibility of the antigen-combining site.

Authors:  V Manivel; N C Sahoo; D M Salunke; K V Rao
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

Review 3.  Clinical trials of antibody therapy.

Authors:  M J Glennie; P W Johnson
Journal:  Immunol Today       Date:  2000-08

4.  A comparative analysis of the immunological evolution of antibody 28B4.

Authors:  J Yin; E C Mundorff; P L Yang; K U Wendt; D Hanway; R C Stevens; P G Schultz
Journal:  Biochemistry       Date:  2001-09-11       Impact factor: 3.162

5.  Native protein sequences are close to optimal for their structures.

Authors:  B Kuhlman; D Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

6.  A simple physical model for binding energy hot spots in protein-protein complexes.

Authors:  Tanja Kortemme; David Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-15       Impact factor: 11.205

7.  Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII.

Authors:  P C Spiegel; M Jacquemin; J M Saint-Remy; B L Stoddard; K P Pratt
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

8.  Conformational Abs recognizing a generic amyloid fibril epitope.

Authors:  Brian O'Nuallain; Ronald Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

9.  How do two unrelated antibodies, HyHEL-10 and F9.13.7, recognize the same epitope of hen egg-white lysozyme?

Authors:  Jaume Pons; Jennifer R Stratton; Jack F Kirsch
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

10.  The 1.85 A resolution crystal structures of tissue factor in complex with humanized Fab D3h44 and of free humanized Fab D3h44: revisiting the solvation of antigen combining sites.

Authors:  K Faelber; D Kirchhofer; L Presta; R F Kelley; Y A Muller
Journal:  J Mol Biol       Date:  2001-10-12       Impact factor: 5.469

View more
  36 in total

1.  Incorporating an allosteric regulatory site in an antibody through backbone design.

Authors:  Olga Khersonsky; Sarel J Fleishman
Journal:  Protein Sci       Date:  2017-03-06       Impact factor: 6.725

Review 2.  Protein structural motifs in prediction and design.

Authors:  Craig O Mackenzie; Gevorg Grigoryan
Journal:  Curr Opin Struct Biol       Date:  2017-04-28       Impact factor: 6.809

3.  AbPredict 2: a server for accurate and unstrained structure prediction of antibody variable domains.

Authors:  Gideon Lapidoth; Jake Parker; Jaime Prilusky; Sarel J Fleishman
Journal:  Bioinformatics       Date:  2019-05-01       Impact factor: 6.937

4.  IsAb: a computational protocol for antibody design.

Authors:  Tianjian Liang; Hui Chen; Jiayi Yuan; Chen Jiang; Yixuan Hao; Yuanqiang Wang; Zhiwei Feng; Xiang-Qun Xie
Journal:  Brief Bioinform       Date:  2021-09-02       Impact factor: 11.622

5.  Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design.

Authors:  Clara T Schoeder; Samuel Schmitz; Jared Adolf-Bryfogle; Alexander M Sevy; Jessica A Finn; Marion F Sauer; Nina G Bozhanova; Benjamin K Mueller; Amandeep K Sangha; Jaume Bonet; Jonathan H Sheehan; Georg Kuenze; Brennica Marlow; Shannon T Smith; Hope Woods; Brian J Bender; Cristina E Martina; Diego Del Alamo; Pranav Kodali; Alican Gulsevin; William R Schief; Bruno E Correia; James E Crowe; Jens Meiler; Rocco Moretti
Journal:  Biochemistry       Date:  2021-03-11       Impact factor: 3.162

6.  Principles for computational design of binding antibodies.

Authors:  Dror Baran; M Gabriele Pszolla; Gideon D Lapidoth; Christoffer Norn; Orly Dym; Tamar Unger; Shira Albeck; Michael D Tyka; Sarel J Fleishman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-25       Impact factor: 11.205

Review 7.  Why reinvent the wheel? Building new proteins based on ready-made parts.

Authors:  Olga Khersonsky; Sarel J Fleishman
Journal:  Protein Sci       Date:  2016-02-22       Impact factor: 6.725

8.  High-accuracy modeling of antibody structures by a search for minimum-energy recombination of backbone fragments.

Authors:  Christoffer H Norn; Gideon Lapidoth; Sarel J Fleishman
Journal:  Proteins       Date:  2016-10-24

9.  RosettaCM for antibodies with very long HCDR3s and low template availability.

Authors:  Pranav Kodali; Clara T Schoeder; Samuel Schmitz; James E Crowe; Jens Meiler
Journal:  Proteins       Date:  2021-07-07

Review 10.  Macromolecular modeling and design in Rosetta: recent methods and frameworks.

Authors:  Julia Koehler Leman; Brian D Weitzner; Steven M Lewis; Jared Adolf-Bryfogle; Nawsad Alam; Rebecca F Alford; Melanie Aprahamian; David Baker; Kyle A Barlow; Patrick Barth; Benjamin Basanta; Brian J Bender; Kristin Blacklock; Jaume Bonet; Scott E Boyken; Phil Bradley; Chris Bystroff; Patrick Conway; Seth Cooper; Bruno E Correia; Brian Coventry; Rhiju Das; René M De Jong; Frank DiMaio; Lorna Dsilva; Roland Dunbrack; Alexander S Ford; Brandon Frenz; Darwin Y Fu; Caleb Geniesse; Lukasz Goldschmidt; Ragul Gowthaman; Jeffrey J Gray; Dominik Gront; Sharon Guffy; Scott Horowitz; Po-Ssu Huang; Thomas Huber; Tim M Jacobs; Jeliazko R Jeliazkov; David K Johnson; Kalli Kappel; John Karanicolas; Hamed Khakzad; Karen R Khar; Sagar D Khare; Firas Khatib; Alisa Khramushin; Indigo C King; Robert Kleffner; Brian Koepnick; Tanja Kortemme; Georg Kuenze; Brian Kuhlman; Daisuke Kuroda; Jason W Labonte; Jason K Lai; Gideon Lapidoth; Andrew Leaver-Fay; Steffen Lindert; Thomas Linsky; Nir London; Joseph H Lubin; Sergey Lyskov; Jack Maguire; Lars Malmström; Enrique Marcos; Orly Marcu; Nicholas A Marze; Jens Meiler; Rocco Moretti; Vikram Khipple Mulligan; Santrupti Nerli; Christoffer Norn; Shane Ó'Conchúir; Noah Ollikainen; Sergey Ovchinnikov; Michael S Pacella; Xingjie Pan; Hahnbeom Park; Ryan E Pavlovicz; Manasi Pethe; Brian G Pierce; Kala Bharath Pilla; Barak Raveh; P Douglas Renfrew; Shourya S Roy Burman; Aliza Rubenstein; Marion F Sauer; Andreas Scheck; William Schief; Ora Schueler-Furman; Yuval Sedan; Alexander M Sevy; Nikolaos G Sgourakis; Lei Shi; Justin B Siegel; Daniel-Adriano Silva; Shannon Smith; Yifan Song; Amelie Stein; Maria Szegedy; Frank D Teets; Summer B Thyme; Ray Yu-Ruei Wang; Andrew Watkins; Lior Zimmerman; Richard Bonneau
Journal:  Nat Methods       Date:  2020-06-01       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.